Table 2.
Anthropometric measures and ultrasonographic findings before and after exenatide therapy.
| Before exenatide treatment | After exenatide treatment | P-value | |
|---|---|---|---|
| BMI (kg/m2) | 43.46 ± 6.01 | 39.60 ± 5.63 | <0.001 |
| Waist circumference (mm) | 126.47 ± 15.10 | 120.49 ± 15.24 | <0.001 |
| Hip circumference (mm) | 132.82 ± 12.86 | 125.96 ± 12.39 | <0.001 |
| Liver largest craniocaudal diameter (mm) | 188.26 ± 17.41 | 180.09 ± 16.49 | <0.001 |
| Subcutaneous fat thickness (mm) | 29.10 ± 5.11 | 23.49 ± 4.98 | <0.001 |
| Visceral fat volume (mm3) | 271.52 ± 41.01 | 227.54 ± 39.42 | <0.001 |
| CIMT (mm) | 1.04 ± 0.11 | 0.75 ± 0.12 | <0.001 |
BMI: body mass index; CIMT: carotid intima-media thickness.